Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propiverine hydrochloride in children with overactive bladder and urinary incontinence
2004-001243-30Phase 4Completed
- Sponsor
- APOGEPHA
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in overactive bladder (OAB) and urinary incontinence (UI) comparing Propiverine hydrochloride (Mictonetten) with Placebo (2 arms). Primary endpoint: micturition frequency per day. Started Nov 2004; status: completed.
02
Drugs
propiverine
03
Conditions
overactive bladder (OAB)urinary incontinence (UI)
Beyond the preview
Go deeper on 2004-001243-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001243-30.